IL40895A - Pyrazolo(1,5a)pyrimidines and their preparation - Google Patents

Pyrazolo(1,5a)pyrimidines and their preparation

Info

Publication number
IL40895A
IL40895A IL40895A IL4089572A IL40895A IL 40895 A IL40895 A IL 40895A IL 40895 A IL40895 A IL 40895A IL 4089572 A IL4089572 A IL 4089572A IL 40895 A IL40895 A IL 40895A
Authority
IL
Israel
Prior art keywords
compound
methyl
bromine
alkyl
halogen
Prior art date
Application number
IL40895A
Other languages
English (en)
Other versions
IL40895A0 (en
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US245870A external-priority patent/US3925385A/en
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of IL40895A0 publication Critical patent/IL40895A0/xx
Publication of IL40895A publication Critical patent/IL40895A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL40895A 1971-12-09 1972-11-22 Pyrazolo(1,5a)pyrimidines and their preparation IL40895A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20653871A 1971-12-09 1971-12-09
US245870A US3925385A (en) 1972-04-20 1972-04-20 6-Carbethoxy-3,7-disubstitutedpyrazolo{8 1,5a{9 pyrimidines
US27346572A 1972-07-20 1972-07-20
US29984072A 1972-10-24 1972-10-24

Publications (2)

Publication Number Publication Date
IL40895A0 IL40895A0 (en) 1973-01-30
IL40895A true IL40895A (en) 1976-12-31

Family

ID=27498614

Family Applications (1)

Application Number Title Priority Date Filing Date
IL40895A IL40895A (en) 1971-12-09 1972-11-22 Pyrazolo(1,5a)pyrimidines and their preparation

Country Status (15)

Country Link
JP (1) JPS4864097A (en:Method)
BE (1) BE792533A (en:Method)
BG (1) BG22401A3 (en:Method)
CH (1) CH603652A5 (en:Method)
DD (1) DD104530A5 (en:Method)
DE (1) DE2257547A1 (en:Method)
GB (1) GB1412017A (en:Method)
HU (1) HU168530B (en:Method)
IE (1) IE37189B1 (en:Method)
IL (1) IL40895A (en:Method)
LU (1) LU66597A1 (en:Method)
NL (1) NL7216539A (en:Method)
NO (1) NO137012C (en:Method)
RO (1) RO62762A (en:Method)
SE (1) SE398751B (en:Method)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
AU557300B2 (en) * 1982-03-16 1986-12-18 Farmitalia Carlo Erba S.P.A. Substituted 1h-pyrazolo(1,5-alpha)pyrimidines and processes for their preparation
ZA831407B (en) * 1982-03-25 1983-11-30 Erba Farmitalia Substituted ethenyl derivatives of 1h-pyrazolo(1,5-a)pyrimidine and process for their preparation
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
DE3533050A1 (de) * 1985-09-17 1987-03-26 Basf Ag 7-amino-azolo(1,5-a)pyrimidine, verfahren zu ihrer herstellung und diese enthaltende fungizide, bzw. deren verwendung als fungizide
CA1330079C (en) * 1988-10-13 1994-06-07 Michihiko Tsujitani Pyrrolo (3,2-e)pyrazolo(1,5-a)pyrimidine derivative and medicine comprising the same
ES2126573T3 (es) * 1991-04-22 1999-04-01 Otsuka Pharma Co Ltd Derivado de pirazol (1,5-a)pirimidina y agente antiinflamatorio que contiene este derivado.
DE4333705C2 (de) * 1993-10-02 2003-10-30 Guenter Ege Arylmethylsubstituierte Pyrazolo-azine, insbesondere 3-Arylmethylpyrazolo[1,5-a]pyrimidine und Verfahren zur Herstellung von 8-Arylmethyl-pyrazolo[5,1-c][1,2,4]triazinen
EP0714898B1 (en) * 1994-06-21 2001-11-14 Otsuka Pharmaceutical Factory, Inc. PYRAZOLO [1,5-a]PYRIMIDINE DERIVATIVE
CN1169149A (zh) * 1995-09-28 1997-12-31 株式会社大制药工场 止痛组合物
FR2771631B1 (fr) 1997-12-03 2001-02-02 Oreal Compositions de teinture des fibres keratiniques contenant des 3-amino pyrazolo-[1,5-a]-pyrimidines, procede de teinture, nouvelles 3-amino pyrazolo- [1,5-a]-pyrimidines et leur procede de preparation
US7161003B1 (en) 2002-09-04 2007-01-09 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
AU2003263071B2 (en) * 2002-09-04 2007-03-15 Merck Sharp & Dohme Llc Pyrazolopyrimidines as cyclin-dependent kinase inhibitors
US7119200B2 (en) * 2002-09-04 2006-10-10 Schering Corporation Pyrazolopyrimidines as cyclin dependent kinase inhibitors
TWI252851B (en) * 2003-07-24 2006-04-11 Ferrer Int 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto
ES2222813B1 (es) * 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
EP2989106B1 (en) 2013-04-25 2016-12-14 Beigene, Ltd. Fused heterocyclic compounds as protein kinase inhibitors
AU2013400609B9 (en) 2013-09-13 2020-03-05 Beigene Switzerland Gmbh Anti-PD1 antibodies and their use as therapeutics and diagnostics
TWI726608B (zh) 2014-07-03 2021-05-01 英屬開曼群島商百濟神州有限公司 抗pd-l1抗體及其作為治療及診斷之用途
CN109475536B (zh) 2016-07-05 2022-05-27 百济神州有限公司 用于治疗癌症的PD-l拮抗剂和RAF抑制剂的组合
EA201990519A1 (ru) 2016-08-16 2019-08-30 Бейджин, Лтд. КРИСТАЛЛИЧЕСКАЯ ФОРМА (S)-7-(1-АКРИЛОИЛПИПЕРИДИН-4-ИЛ)-2-(4-ФЕНОКСИФЕНИЛ)-4,5,6,7-ТЕТРАГИДРОПИРАЗОЛО[1,5-a]ПИРИМИДИН-3-КАРБОКСАМИДА, ЕЕ ПОЛУЧЕНИЕ И ПРИМЕНЕНИЯ
EP3500299B1 (en) 2016-08-19 2023-12-13 BeiGene Switzerland GmbH Combination of zanubrutinib with an anti-cd20 or an anti-pd-1 antibody for use in treating cancer
CN110461847B (zh) 2017-01-25 2022-06-07 百济神州有限公司 (S)-7-(1-(丁-2-炔酰基)哌啶-4-基)-2-(4-苯氧基苯基)-4,5,6,7-四氢吡唑并[1,5-a]嘧啶-3-甲酰胺的结晶形式、其制备及用途
EP3645569A4 (en) 2017-06-26 2021-03-24 BeiGene, Ltd. IMMUNOTHERAPY FOR LIVER CELL CARCINOMA
WO2019034009A1 (en) 2017-08-12 2019-02-21 Beigene, Ltd. BTK INHIBITOR WITH ENHANCED DOUBLE SELECTIVITY
CN111801334B (zh) 2017-11-29 2023-06-09 百济神州瑞士有限责任公司 使用包含btk抑制剂的组合治疗惰性或侵袭性b-细胞淋巴瘤
JP2022538214A (ja) 2019-06-10 2022-09-01 ベイジーン スウィッツァーランド ゲーエムベーハー ブルトン型チロシンキナーゼ阻害剤を含む経口固体錠剤及びその調製方法
US11786531B1 (en) 2022-06-08 2023-10-17 Beigene Switzerland Gmbh Methods of treating B-cell proliferative disorder

Also Published As

Publication number Publication date
DD104530A5 (en:Method) 1974-03-12
HU168530B (en:Method) 1976-05-28
JPS4864097A (en:Method) 1973-09-05
IE37189L (en) 1973-06-09
IE37189B1 (en) 1977-05-25
SE398751B (sv) 1978-01-16
IL40895A0 (en) 1973-01-30
DE2257547A1 (de) 1973-06-14
CH603652A5 (en:Method) 1978-08-31
NL7216539A (en:Method) 1973-06-13
RO62762A (fr) 1978-05-15
LU66597A1 (en:Method) 1973-03-15
BG22401A3 (bg) 1977-02-20
GB1412017A (en) 1975-10-29
BE792533A (fr) 1973-06-08
NO137012C (no) 1977-12-14
NO137012B (no) 1977-09-05

Similar Documents

Publication Publication Date Title
IL40895A (en) Pyrazolo(1,5a)pyrimidines and their preparation
CA2422379A1 (en) Pyrazole compounds useful as protein kinase inhibitors
CA2214086C (en) Pyrazole derivatives and processes for the preparation thereof
ES2877678T3 (es) Método de preparación para un compuesto de pirrolopirimidina quiral
KR20230159419A (ko) Tyk2 억제제 및 이의 용도
YU1501A (sh) Derivati hinolina
HU230344B1 (hu) Pirrolopirimidinon-származékok, a vegyületek előállítása és alkalmazása
CA2029265A1 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
MXPA03010529A (es) Derivados de imidazol [1,5a]pirimido[5,4-d]benzazepina, como moduladores del receptor gaba a.
BG103785A (en) Pyrrolo[2,3-d]pyrimidines and their application as tyrosine kinase inhibitors
IL160915A0 (en) Indolizines inhibiting kinase proteins
AP1425A (en) Quinoline derivatives.
KR20230159421A (ko) Tyk2 억제제 및 이의 용도
CA2628224A1 (en) Vinyl-pyrrolidinone cephalosporins with basic substituents
HRP20010512B1 (en) Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
CA2389491A1 (en) Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors
EP0236673B1 (en) Process for quinoline-3-carboxylic acid antibacterial agents
MXPA05008183A (es) Proceso para preparar pirrolotriazina como inhibidores de cinasa.
MX2007003722A (es) Derivados de 6-(piridinil)-4-pirimidona como inhibidores de la tau proteina cinasa 1.
ATE389653T1 (de) 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen
MY132507A (en) Process for substituted pyridines
ES2279361T3 (es) Derivados de (6-(fenoxi)-pirido-3,4-dipirimidin-2-il)-amina como inhibidores de p38 kinasa para el tratamiento de estados inflamatorios tal como artritis reumatoide.
GB937724A (en) New pyrazolo-pyrimidines and process for the preparation thereof
Ochiai et al. Discovery of new orally active phosphodiesterase (PDE4) inhibitors
IL97913A0 (en) Heterocyclic compounds,their preparation and pharmaceutical compositions containing them